메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Su-In Kim (Department of Hematology-Oncology Chonnam National University Hwasun Hospital and Chonnam National) Sung-Hoon Jung (Department of Hematology-Oncology Chonnam National University Hwasun Hospital and Chonnam National) Ho-Young Yhim (Department of Internal Medicine Jeonbuk National University Hospital Jeonbuk National University Me) Jae-Cheol Jo (Department of Internal Medicine Ulsan University Hospital University of Ulsan College of Medicine U) Ga-Young Song (Department of Hematology-Oncology Chonnam National University Hwasun Hospital and Chonnam National) Mihee Kim (Department of Hematology-Oncology Chonnam National University Hwasun Hospital and Chonnam National) Seo-Yeon Ahn (Department of Hematology-Oncology Chonnam National University Hwasun Hospital and Chonnam National) Jae-Sook Ahn (Department of Hematology-Oncology Chonnam National University Hwasun Hospital and Chonnam National) Deok-Hwan Yang (Department of Hematology-Oncology Chonnam National University Hwasun Hospital and Chonnam National) Hyeoung-Joon Kim (Department of Hematology-Oncology Chonnam National University Hwasun Hospital and Chonnam National) Je-Jung Lee (Department of Hematology-Oncology Chonnam National University Hwasun Hospital and Chonnam National)
저널정보
대한혈액학회 Blood Research Blood Research Vol.57 No.1
발행연도
2022.3
수록면
51 - 58 (8page)
DOI
10.5045/br.2021.2021176

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background Although survival outcomes of multiple myeloma (MM) have improved with the development of new and effective agents, infection remains the major cause of morbidity and mortality. Here, we evaluated the efficacy of levofloxacin prophylaxis (in a real-world setting) during bortezomib, melphalan, and prednisone (VMP) therapy in elderly patients with newly diagnosed MM. Methods This study retrospectively analyzed the records of patients with newly diagnosed MM treated with the VMP regimen between February 2011 and September 2020 at three institutes of the Republic of Korea. Results Of a total of 258 patients, 204 (79.1%) received levofloxacin prophylaxis during VMP therapy. The median number of levofloxacin prophylaxis cycles was 4 (range, 1?9), but 10 patients did not complete the planned prophylaxis because of side effects. Sixty-six patients (25.5%) experienced severe infections during VMP therapy, most of which (74.7%) occurred within the first four cycles of VMP therapy regardless of levofloxacin prophylaxis status. Early severe infection was significantly associated with poor survival. In multivariate analysis, levofloxacin prophylaxis was significantly associated with a lower risk in early severe infection. Conclusion Our findings suggest that levofloxacin prophylaxis should be considered at least during the first four cycles of VMP therapy in elderly patients with newly diagnosed MM.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0